Compare ADMA & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | KAI |
|---|---|---|
| Founded | 2004 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.3B |
| IPO Year | N/A | N/A |
| Metric | ADMA | KAI |
|---|---|---|
| Price | $19.86 | $289.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $28.50 | ★ $340.00 |
| AVG Volume (30 Days) | ★ 2.9M | 141.0K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | ★ 205.35 | N/A |
| EPS | 0.86 | ★ 8.65 |
| Revenue | $488,559,000.00 | ★ $1,024,074,000.00 |
| Revenue This Year | $22.19 | N/A |
| Revenue Next Year | $24.33 | $10.56 |
| P/E Ratio | ★ $23.11 | $33.78 |
| Revenue Growth | ★ 27.63 | N/A |
| 52 Week Low | $13.50 | $244.87 |
| 52 Week High | $25.67 | $409.73 |
| Indicator | ADMA | KAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.02 | 57.58 |
| Support Level | $19.13 | $276.80 |
| Resistance Level | $20.22 | $300.44 |
| Average True Range (ATR) | 0.73 | 9.69 |
| MACD | 0.05 | 2.66 |
| Stochastic Oscillator | 79.44 | 72.75 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.